TYRA vs KARD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TYRA · TYRA BIOSCIENCES, INC.$21.15 ▲ 1.24%
KARD · Kardigan$15.52 ▲ 11.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TYRA -25.3%
- KARD -29.5%
Head to head
| Metric | TYRA | KARD |
|---|---|---|
| Price | $21.15 | $15.52 |
| Change today | ▲ 1.24% | ▲ 11.98% |
| Market cap | $1.45B | $1.45B |
| Return, 3 months | -19.4% | -26.4% |
| Return, year to date | -19.6% | – |
| Return, 1 year | +47.7% | – |
| P/E (TTM) | – | – |
| P/B | 4.1 | 2.4 |
| P/E percentile vs own 5y | 59th | 82nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -62.1% | -102.3% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -45.3% | -46.9% |
| Analyst target vs. price | +124.1% | +160.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 49 | 56 |
| 30-day volatility | 41.9% | 85.0% |
| Max drawdown, 1 year | -53.2% | -51.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TYRA is the largest of the group by market value.
- TYRA has been the calmest stock over the last 30 days.